Biophytis SA (Nasdaq CM: BPTS, Euronext Growth Paris: ALBPS), (“Biophytis” or the “Company”), a clinical-stage biotechnology company specializing in the development of treatments that aim to slow down the degenerative processes linked to aging and improve the functional outcomes of patients suffering from age-related, neuromuscular and respiratory diseases, today announces its participation in the BIO-Europe conference being held in Munich, Germany, from November 6 to 8, 2023.